219 related articles for article (PubMed ID: 37707954)
1. A cyclic pyrrole-imidazole polyamide reduces pathogenic RNA in CAG/CTG triplet repeat neurological disease models.
Ikenoshita S; Matsuo K; Yabuki Y; Kawakubo K; Asamitsu S; Hori K; Usuki S; Hirose Y; Bando T; Araki K; Ueda M; Sugiyama H; Shioda N
J Clin Invest; 2023 Nov; 133(22):. PubMed ID: 37707954
[TBL] [Abstract][Full Text] [Related]
2. Length-dependent CTG·CAG triplet-repeat expansion in myotonic dystrophy patient-derived induced pluripotent stem cells.
Du J; Campau E; Soragni E; Jespersen C; Gottesfeld JM
Hum Mol Genet; 2013 Dec; 22(25):5276-87. PubMed ID: 23933738
[TBL] [Abstract][Full Text] [Related]
3. Strong and Specific Recognition of CAG/CTG Repeat DNA (5'-dWGCWGCW-3') by a Cyclic Pyrrole-Imidazole Polyamide.
Hirose Y; Ohno T; Asamitsu S; Hashiya K; Bando T; Sugiyama H
Chembiochem; 2022 Jan; 23(2):e202100533. PubMed ID: 34796607
[TBL] [Abstract][Full Text] [Related]
4. Triplet repeat-derived siRNAs enhance RNA-mediated toxicity in a Drosophila model for myotonic dystrophy.
Yu Z; Teng X; Bonini NM
PLoS Genet; 2011 Mar; 7(3):e1001340. PubMed ID: 21437269
[TBL] [Abstract][Full Text] [Related]
5. MSH3 polymorphisms and protein levels affect CAG repeat instability in Huntington's disease mice.
Tomé S; Manley K; Simard JP; Clark GW; Slean MM; Swami M; Shelbourne PF; Tillier ER; Monckton DG; Messer A; Pearson CE
PLoS Genet; 2013; 9(2):e1003280. PubMed ID: 23468640
[TBL] [Abstract][Full Text] [Related]
6. CAG repeat RNA as an auxiliary toxic agent in polyglutamine disorders.
Wojciechowska M; Krzyzosiak WJ
RNA Biol; 2011; 8(4):565-71. PubMed ID: 21593608
[TBL] [Abstract][Full Text] [Related]
7. Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy.
Timchenko LT; Timchenko NA; Caskey CT; Roberts R
Hum Mol Genet; 1996 Jan; 5(1):115-21. PubMed ID: 8789448
[TBL] [Abstract][Full Text] [Related]
8. CAG repeats mimic CUG repeats in the misregulation of alternative splicing.
Mykowska A; Sobczak K; Wojciechowska M; Kozlowski P; Krzyzosiak WJ
Nucleic Acids Res; 2011 Nov; 39(20):8938-51. PubMed ID: 21795378
[TBL] [Abstract][Full Text] [Related]
9. A CTG repeat-selective chemical screen identifies microtubule inhibitors as selective modulators of toxic CUG RNA levels.
Reddy K; Jenquin JR; McConnell OL; Cleary JD; Richardson JI; Pinto BS; Haerle MC; Delgado E; Planco L; Nakamori M; Wang ET; Berglund JA
Proc Natl Acad Sci U S A; 2019 Oct; 116(42):20991-21000. PubMed ID: 31570586
[TBL] [Abstract][Full Text] [Related]
10. Huntington's and myotonic dystrophy hESCs: down-regulated trinucleotide repeat instability and mismatch repair machinery expression upon differentiation.
Seriola A; Spits C; Simard JP; Hilven P; Haentjens P; Pearson CE; Sermon K
Hum Mol Genet; 2011 Jan; 20(1):176-85. PubMed ID: 20935170
[TBL] [Abstract][Full Text] [Related]
11. CAG RNAs induce DNA damage and apoptosis by silencing
Peng S; Guo P; Lin X; An Y; Sze KH; Lau MHY; Chen ZS; Wang Q; Li W; Sun JK; Ma SY; Chan TF; Lau KF; Ngo JCK; Kwan KM; Wong CH; Lam SL; Zimmerman SC; Tuccinardi T; Zuo Z; Au-Yeung HY; Chow HM; Chan HYE
Proc Natl Acad Sci U S A; 2021 May; 118(19):. PubMed ID: 33947817
[TBL] [Abstract][Full Text] [Related]
12. RNA FISH for detecting expanded repeats in human diseases.
Urbanek MO; Krzyzosiak WJ
Methods; 2016 Apr; 98():115-123. PubMed ID: 26615955
[TBL] [Abstract][Full Text] [Related]
13. Antisense transcription of the myotonic dystrophy locus yields low-abundant RNAs with and without (CAG)n repeat.
Gudde AEEG; van Heeringen SJ; de Oude AI; van Kessel IDG; Estabrook J; Wang ET; Wieringa B; Wansink DG
RNA Biol; 2017 Oct; 14(10):1374-1388. PubMed ID: 28102759
[TBL] [Abstract][Full Text] [Related]
14. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2.
Mankodi A; Urbinati CR; Yuan QP; Moxley RT; Sansone V; Krym M; Henderson D; Schalling M; Swanson MS; Thornton CA
Hum Mol Genet; 2001 Sep; 10(19):2165-70. PubMed ID: 11590133
[TBL] [Abstract][Full Text] [Related]
15. Huntington's disease--like 2 is associated with CUG repeat-containing RNA foci.
Rudnicki DD; Holmes SE; Lin MW; Thornton CA; Ross CA; Margolis RL
Ann Neurol; 2007 Mar; 61(3):272-82. PubMed ID: 17387722
[TBL] [Abstract][Full Text] [Related]
16. Stabilization of expanded (CTG)•(CAG) repeats by antisense oligonucleotides.
Nakamori M; Gourdon G; Thornton CA
Mol Ther; 2011 Dec; 19(12):2222-7. PubMed ID: 21971425
[TBL] [Abstract][Full Text] [Related]
17. Modelling and inference reveal nonlinear length-dependent suppression of somatic instability for small disease associated alleles in myotonic dystrophy type 1 and Huntington disease.
Higham CF; Monckton DG
J R Soc Interface; 2013 Nov; 10(88):20130605. PubMed ID: 24047873
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas Applications in Myotonic Dystrophy: Expanding Opportunities.
Raaijmakers RHL; Ripken L; Ausems CRM; Wansink DG
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357652
[TBL] [Abstract][Full Text] [Related]
19. Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels.
Rué L; Bañez-Coronel M; Creus-Muncunill J; Giralt A; Alcalá-Vida R; Mentxaka G; Kagerbauer B; Zomeño-Abellán MT; Aranda Z; Venturi V; Pérez-Navarro E; Estivill X; Martí E
J Clin Invest; 2016 Nov; 126(11):4319-4330. PubMed ID: 27721240
[TBL] [Abstract][Full Text] [Related]
20. Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features.
Dansithong W; Wolf CM; Sarkar P; Paul S; Chiang A; Holt I; Morris GE; Branco D; Sherwood MC; Comai L; Berul CI; Reddy S
PLoS One; 2008; 3(12):e3968. PubMed ID: 19092997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
